Search Results
Nov 07, 2025, 09:00 ET CREATE Medicines Announces Positive First-in-Human Results for MT-302
data provide important mechanistic insights into how in vivo programmed myeloid cells behave within the tumor microenvironment," said Rasha Cosman BSc (Med), MBBS, FRACP, Head of the Early Phase Clinical Trials Unit at The Kinghorn Cancer Centre, St. Vincents Hospital Sydney, "The degree of remodeling observed,
More news about: CREATE Medicines, Inc.
Nov 07, 2025, 08:49 ET 46% Drop in Mental Energy? The FoundationMED Report That Has Every Industry on Edge
offices, no sector is immune. The findings suggest a universal pattern of energy collapse impacting focus, creativity, and emotional regulation. Foundation Med emphasizes that organizations can no longer treat brain health as an individual concern but as a core metric of performance and sustainability.
More news about: FoundationMED
Nov 07, 2025, 08:30 ET FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma
doi:10.1038/s41467-021-22140-03 Maura, F, Bergsagel PL. Targeting the Tumor and the Immune System in Smoldering Multiple Myeloma. N Engl J Med. 2025;392:1858-1860. doi: 10.1056/NEJMe25042734 American Cancer Society. Myeloma Cancer Statistics. Accessed June 2025. Available
More news about: Halozyme Therapeutics, Inc.
Nov 07, 2025, 08:11 ET Outcomes Rocket and Censinet Announce Exclusive AI-Focused Healthcare Series from AI Med 2025
collaborative series recorded at AI Med 2025. SAN DIEGO, Nov. 7, 2025 /PRNewswire/ -- Outcomes Rocket and Censinet today announced the AI Med 2025 Insights Series, a
More news about: Outcomes Rocket
Nov 07, 2025, 07:30 ET Laborie Announces Agreement to Acquire the JADA® System from Organon
standard of care in postpartum hemorrhage (PPH) management" said Organon interim Chief Executive Officer (CEO) Joseph Morrissey. "This transaction puts a med tech asset in the hands of Laborie, a leading medical technology innovator with an established history in maternal health well-positioned to further
More news about: Laborie Medical Technologies
Nov 06, 2025, 17:07 ET DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
doi:10.1038/s41467-021-22140-04 Maura, F, Bergsagel PL. Targeting the Tumor and the Immune System in Smoldering Multiple Myeloma. N Engl J Med. 2025;392:1858-1860. doi: 10.1056/NEJMe25042735 American Cancer Society. Myeloma Cancer Statistics. Accessed November 2025. Available
More news about: Johnson & Johnson
Nov 06, 2025, 14:30 ET Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek®
Garvey WT, Blüher M, Osorto Contreras CK, et al. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2025;393:635–647. Kaplan LM, Golden A, Jinnett K, et al. Perceptions of barriers to effective obesity care: results from
More news about: NOVO NORDISK INC.
Nov 06, 2025, 14:30 ET Novo Nordisk's CagriSema was associated with significant reduction in blood pressure and showed anti-inflammatory effects while reducing the proportion of patients at risk of developing heart disease over time in new analyses at ObesityWeek®
Garvey WT, Blüher M, Osorto Contreras CK, et al. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2025;393:635–647. Kaplan LM, Golden A, Jinnett K, et al. Perceptions of barriers to effective obesity care: results from
More news about: NOVO NORDISK INC.
Nov 06, 2025, 09:00 ET GC Biopharma Supports New Insights into Education, Safety, and Patient Outcomes in Ig Therapy Care at the 2025 IgNS Annual Meeting
1. Kang GB, Huber A, Lee J, et al. Cation exchange chromatography removes FXIa from a 10% intravenous immunoglobulin preparation. Front Cardiovasc Med. 2023;10:1253177. 2. ALYGLO Prescribing Information. GC Biopharma; 2023.
More news about: GC Biopharma USA Inc.
Nov 06, 2025, 06:30 ET BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
Biosciences and Diagnostic Solutions business with Waters Corporation around the end of the first quarter of calendar year 2026. New BD will be a leading Med Tech company making a profound impact on health care and patients worldwide. By focusing on growth in attractive markets and executing BD Excellence,
More news about: BD (Becton, Dickinson and Company)
Nov 06, 2025, 06:21 ET Scandic Trust Group stärker sitt försäljningsnätverk med First Idea Consultant
tjänster med modern teknik. En av tillgångarna är ett utilitets-fintechsystem (SNC) som fungerar som en bro mellan den digitala och den verkliga ekonomin. Genom SNC kan användare få tillgång till tjänster och lojalitetsprogram kan hanteras. "SCADIC PAY" byggs ut som en icke-depåbaserad åtkomst med Web3,
More news about: The HongKong Telegraph
Nov 05, 2025, 12:17 ET Miramont Wellness Centers Joins National Initiative to Support Firefighter's Mental Wellness
BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more.
More news about: Miramont Wellness Centers
Nov 05, 2025, 11:23 ET W&H Medical Unveils the Only FDA-Cleared Piezo & Drill Combo Console for Rhinoplasty and Facial Surgery
– optimized for closed rhinoplasty "For me, the new surgical system from W&H MED is an all-in-one solution, as ultrasonic technology and burs are integrated in one device. I was involved in the development of the exclusive piezo tip
More news about: W&H Impex Inc.
Nov 05, 2025, 09:00 ET ProRx Introduces New Liquid Nanoemulsion Delivery System to Support Enhanced Absorption, Bioavailability, and Patient Convenience
committed to delivering safe, compliant, and high-quality compounded sterile and nonsterile preparations to physician practices, medical clinics, and med spas across the country. With a focus on preventative health, regulatory excellence, reliability, and customer service, ProRx partners with providers
More news about: ProRx Pharma
Nov 05, 2025, 08:34 ET CNS Summit releases annual Digital Innovation Index
Nov. 5, 2025 /PRNewswire/ -- The CNS Summit Digital Innovation Index, created in partnership with IDEA Pharma, a division of SAI Med Partners, was unveiled during the CNS Summit annual meeting on November 4. The Index continues to assess and rank biopharma companies' progress in digital
More news about: CNS Summit
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
Atlanta, Georgia. Wharton S, Lingvay I, Bogdanski P, et al. Oral Semaglutide 25 mg in Adults with Overweight or Obesity. N Engl J Med. 2025; 393:1077-1087. DOI: 10.1056/NEJMoa2500969. Novo Nordisk A/S. Data on file. Oral Semaglutide 25 mg FDA
More news about: NOVO NORDISK INC.
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
Atlanta, Georgia. Wharton S, Lingvay I, Bogdanski P, et al. Oral Semaglutide 25 mg in Adults with Overweight or Obesity. N Engl J Med. 2025; 393:1077-1087. DOI: 10.1056/NEJMoa2500969. Novo Nordisk A/S. Data on file. Oral Semaglutide 25 mg FDA
More news about: NOVO NORDISK INC.
Nov 05, 2025, 07:30 ET DeepL presenterar nästa generations AI-verktyg för språk och en banbrytande produktivitetslösning
fortsatta innovationer inom Språk-AI med lanseringen av Customization Hub och tillkännagivandet av över 70 nya språk till plattformen. Jarek Kutylowski, CEO (VD) och grundare av DeepL, säger: "I takt med att DeepL går vidare med sin bredare mission är vår vision
More news about: DeepL
Nov 05, 2025, 00:30 ET Tinnitus UK Rates Lenire as Most Effective Treatment Option
References Conlon et al., Sci. Transl. Med. 12, eabb2830 (2020) Conlon et al., Nature Communications (2022),
More news about: Neuromod Devices
Nov 04, 2025, 16:05 ET Cryoport Reports Third Quarter 2025 Financial Results
Monitoring Solutions for these dewars, combining its trusted cryogenic systems with our advanced, real-time condition monitoring technology supplied by Tec4med, another Cryoport company. Our pipeline of new innovative products and services, including IntegriCell, positions Cryoport well to capture greater
More news about: Cryoport, Inc.
Nov 04, 2025, 09:14 ET Healthcare Experts to Break Down Approaching Compliance Cliffs as Big Beautiful Bill Reshapes Reimbursement
www.1sthcc.com. About Med USA Med USA is a trusted leader in medical billing, revenue cycle management, and compliance services. With over 40 years of experience, Med USA partners with healthcare organizations nationwide to optimize revenue
More news about: First Healthcare Compliance
Nov 03, 2025, 10:30 ET ECG Cable & Lead Wire Market worth $3.76 billion by 2030 with 6.8% CAGR | MarketsandMarkets™
Curbell Medical Products, Inc. (US), Shanghai Berry Electronic Tech Co., Ltd (China), Unimed Medical Supplies Inc. (China), Amydi-med Electronic Technology Co., Ltd. (China), Med-Linket Corp (China), Sorimex (Poland), Nuova Gmbh (Germany), LUMED Srl (Italy), and Shenzhen UpnMed Equipment Co., Ltd.(China).
More news about: MarketsandMarkets
Nov 03, 2025, 09:00 ET Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting
Cierpicki T, Grembecka J. Challenges and opportunities in targeting the menin-MLL Interaction. Future Med Chem. 2014; 6(4):447-462. doi:10.4155/fmc.13.214. Matkar S, Thiel A, Hua X. Menin: a scaffold protein that controls gene
More news about: Sumitomo Pharma America
Nov 03, 2025, 08:00 ET OFD Life Sciences Bolsters Quality and R&D Leadership Amid Growing Demand for Biotech Innovation
Strategic leadership additions deepen scientific rigor and quality systems of OFD Life Sciences to scale innovation in biopharma, med tech, and health markets ALBANY, Ore., Nov.
More news about: OFD Life Sciences
Nov 03, 2025, 08:00 ET Tecnologia Volnewmer promove estímulo natural para produção de novo colágeno
Latina. Formada pelas empresas MedSystems, BeautySystems, Advance Vision, Aeskins, Vydence Medical, Botoclinic, MedSystems Academy, Beauty Academy e Med Banking, a instituição oferece soluções tecnológicas inovadoras para transformar a vida de pacientes, médicos, profissionais de estética e redes, impulsionando
More news about: Grupo MedSystems